contractual agreements

Sanofi gains full control of nirsevimab in US with new contractual agreements

(IN BRIEF) Sanofi has simplified its contractual arrangements with AstraZeneca and Sobi for the development and commercialization of Beyfortus (nirsevimab)…

1 year ago